POSTER SESSION V
Wednesday, March 24, 2010   —  9:30 AM - 12:00 Noon
Exhibit Hall


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


GENITOURINARY PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
81 Clinicopathological Study of Urothelial Carcinoma of the Renal Pelvis: A Proposal for New pT3 Criteria (998)
T Tsuzuki, N Sassa, M Fukatsu, T Fujita, A Katsuno, T Nishikimi, R Hattori, M Gotoh - Nagoya Daini Red Cross Hopital and Nagoya University, Nagoya, Japan; Komaki, Komaki Municipal Hospital, Japan; Chyukyo Hospital, Nagoya, Japan; Okazaki Municipal Hospital, Okazaki, Japan 		Add
82 Primary Small Cell Carcinoma of the Renal Pelvis: A Report of 11 Cases (980)
Q Si, M Stanton, P Tamboli, BA Czerniak, CC Guo - University of Texas MD Anderson Cancer Center, Houston, TX 		Add
83 Renal Pelvic Urothelial Carcinoma with Divergent Morphology (1021)
GQ Xiao, J Chow, PD Unger - Mount Sinai School of Medicine, New York, NY 		Add
84 IgG4-Associated Inflammatory Pseudotumor of Ureter; a Report of Three Cases (888)
SA Kim, SR Lee, J Huh, SS Shen, JY Ro - University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea; The Methodist Hospital, Weill Medical College of Cornell University, Houston, TX 		Add
85 Smooth Muscle Component of Renal Angiomyolipoma Is Polysomic for Chromosome 7 (809)
O Chang, S Madugula, L Deane, E Wiley, G Chappell, V Lindgren, S Setty - University of Illinois at Chicago, Chicago, IL 		Add
86 Immunohistochemical Study of Wilms'Tumor Gene 1 in Angiomyolipoma of the Kidney: Dual Role in Tumorigenesis? (951)
R Rawson, DE Westfall, MB Amin, RS Parakh, BL Balzer - Cedars-Sinai Medical Center, Los Angeles, CA 		Add
87 Intratumoral Fat and Concomitant Angiomyolipoma: A Potential Pitfall in Staging and Diagnosis of Renal Cell Carcinoma (777)
M Aron, H Aydin, L Sercia, C Magi-Galluzzi, M Zhou - Cleveland Clinic, Cleveland, OH 		Add
88 Cytogenetic Analysis Demonstrates Relatively Conserved Karyotypes When Taken from Multiple Areas of Individual Renal Cell Carcinomas (858)
M Gupta, K Gill, P Dal Cin, MS Hirsch - Brigham and Womens Hospital, Boston, MA 		Add
89 Real-Time PCR Validation of Micro-RNA Array Analysis for Renal Neoplasms (899)
A Liang, L Kelly, J Burger, C Sciulli, R Dhir, W LaFramboise - University of Pittsburgh Medical Center, Pittsburgh, PA 		Add
90 Tyrosine Kinase Inhibitor Sunitinib Targets the Vasculature of Clear Cell Renal Cell Carcinoma: A Histological and Immunocytochemical Study of Treatment Effect (873)
J Huang, A Thomas, K Simmerman, L Sercia, C Magi-Galluzzi, S Campbell, B Rini, M Zhou - Cleveland Clinic, Cleveland, OH 		Add
91 Automated Image Analysis of Microvascular Density in Clear Cell Renal Cell Carcinoma and Its Prognostic Utility (827)
W Dubinski, V Iakovlev, M Gabril, Y Youssef, K Kovacs, S Metias, M Mankaruous, GM Yousef - St. Michael's Hospital, Toronto, ON, Canada; London Health Sciences Center, London, ON, Canada 		Add
92 Differential Expression of Cell Cycle Regulated and Tumor Suppressor Gene Proteins in Localised and Advanced Prostatic Adenocarcinoma (784)
C Barrett, R Flavin, A Murphy, B Loftus, O Sheils, JJ O'Leary - Trinity College Dublin, Dublin, Ireland; Adelaide and Meath Hospital, Dublin, Ireland 		Add
93 Does the Inverse Immunoexpression Pattern of Nestin and Androgen Receptor Predict Treatment Failure in Patients with Prostatic Adenocarcinoma? (879)
J Jani, C Cohen, AO Osunkoya - Emory University School of Medicine, Atlanta, GA 		Add
94 PTEN Protein Loss by IHC Is an Adverse Prognostic Indicator in a High Risk Surgical Cohort of Prostate Cancer Patients (909)
TL Lotan, S Sutcliffe, B Gurel, BH Park, E Humphries, AW Partin, M Han, PC Walsh, AM De Marzo - Johns Hopkins Hospitals, Baltimore, MD 		Add
95 Transferrin Receptor Expression in a Nested Case-Control Prostate Cancer Cohort (910)
V Macias, BM Henry, GA Hartung, JR Shah, T Nazir, AK Balla - University of Illinois at Chicago, Chicago, IL 		Add
96 Activating Transcription Factor 3 Protein Expression in Prostatic Adenocarcinomas (959)
JS Ross, C Yan, GM Sheehan, CE Sheehan, T Nazeer, HAG Fisher, BM Mian, BVS Kallakury - Albany Medical College, Albany, NY; Georgetown University Hospital, Washington, DC 		Add
97 The Expression of Serum/Glucocorticoid Regulated Kinase 1 and Glucocorticoid Receptor in Prostatic Tissue (824)
SS Daniel, E Chung, M Tretiakova, S Conzen, H Al-Ahmadie - University of Chicago, Chicago, IL 		Add
98 Overexpression of Phospholipase D1 in Prostatic Adenocarcinoma: Pathogenetic and Therapeutic Implications (1033)
B Zhao, RE Brown - University of Texas - Medical School, Houston, TX 		Add
99 Tau Protein Expression in Recurrent and Non-Recurrent Prostatic Adenocarcinoma (851)
MP Gailey, G Lee, BR De Young - University of Iowa Hospitals and Clinics, Carver College of Medicine, Iowa City, IA 		Add
100 Overexpression of AKT in Prostate Cancers and Association with an Aggressive Tumor Type (992)
H Takahashi, T Yamamoto, M Furusato, S Egawa, H Hano - The Jikei University School of Medicine, Tokyo, Japan 		Add
101 The Expression of Vitamin D Associated Markers in High Grade Prostatic Intraepithelial Neoplasia (967)
S Sasturkar, A Blutreich, TW He, M Nagar, J Small, L Chiriboga, R Hayes, J Melamed, J Ahn - NYU School of Medicine, New York, NY 		Add
102 A Tissue Microarray Study of mTORC1 Pathway Expression in High Grade Prostatic Intraepithelial Neoplasia and Prostatic Adenocarcinoma (837)
S Evren, G Lockwood, N Fleshner, J Sweet - University Health Network, Toronto, ON, Canada 		Add
103 Elevated Expression of Cancer-Associated Proliferating Cell Nuclear Antigen in High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer (1015)
X Wang, RJ Hickey, LH Malkas, MO Koch, S Zhang, GE Sandusky, DJ Grignon, JN Eble, L Cheng - Indiana University School of Medicine, Indianapolis, IN 		Add
104 FoxM1 Immunohistochemical Expression Profiles in Prostatic Adenocarcinoma (785)
TL Bartholow, AV Parwani - University of Pittsburgh School of Medicine, Pittsburgh, PA 		Add
105 Immunohistochemical Expression of Radixin and Moesin in Prostatic Adenocarcinoma (786)
TL Bartholow, AV Parwani - University of Pittsburgh School of Medicine, Pittsburgh, PA 		Add
106 Mycobacterium Abscessus Granulomatous Prostatitis (818)
AY Chuang, MH Tsou, SJ Chang, LY Yang - Koo Fundation Sun Yat-Sen Cancer Center, Taipei, Taiwan 		Add
107 Subcellular Localization of Lipocalin-2/NGAL Correlates with Histologic Type and Grade of Renal Cell Carcinomas (898)
JA Levesque, JS Ross, CE Sheehan, A Hayner-Buchan - Albany Medical College, Albany, NY 		Add
108 Overexpression of Cancer Stem Cell Markers in Renal Cell Carcinoma (915)
A Matta, S El Jamal, HH Zhang, N Gokden, CY Fan - University of Arkansas for Medical Sciences; John L. McClellan Memorial Veterans Hospital and UAMS, Little Rock, AR 		Add
109 Immunohistochemical Expression of Ulex Europaeus Agglutinin-1 in the Spectrum of Adult Renal Epithelial Neoplasms - A Study of 165 Cases (1005)
M Vankalakunti, DE Westfall, RS Parakh, R Gupta, RB Shah, M Amin, AM Gown, LC Goldstein, MB Amin - Cedars-Sinai Medical Center, Los Angeles, CA; University of Michigan, Ann Arbor, MI; William Beaumont Hospital, Royal Oak, MI; PhenoPath Laboratories, Seattle, WA 		Add
110 Expression Patterns of Markers for Targeted Therapies in Renal Cell Carcinoma (976)
SG Sharma, N Gokden - University of Arkansas for Medical Sciences, Little Rock, AR 		Add
111 Cell Surface Peptidases CD13 and CD10 in Renal Cell Neoplasms (852)
S Gobbo, M Brunelli, D Segala, E Munari, M Chilosi, F Menestrina, G Martignoni - University of Verona, Verona, Italy 		Add
112 IMP-3 Is an Independent Prognostic Marker in Clear Cell Renal Cell Carcinoma (872)
J Huang, P Elson, H Aydin, L Sercia, K Simmerman, B Rini, M Zhou - Cleveland Clinic, Cleveland, OH 		Add
113 Expression of Caveolin-1, PAX2 and Survivin in Clear Cell Renal Cell Carcinoma: No Evidence for Prognostic Significance (884)
D Kankaya, S Kiremitci, O Tulunay, S Baltaci - Medical School of Ankara University, Ankara, Turkey 		Add
114 Impact of Epidermal Growth Factor Receptor, Gelsolin, NF-kB, and p53 Expression on Clinicopathological Parameters in Clear Cell Renal Cell Carcinoma (885)
D Kankaya, S Kiremitci, O Tulunay, S Baltaci - Medical School of Ankara University, Ankara, Turkey 		Add
115 Expression Pattern of Epidermal Growth Factor Receptor in Clear Cell Renal Cell Carcinoma: Association with Clinicopathological Features and Clinical Outcome (890)
S Kiremitci, D Kankaya, O Tulunay, S Baltaci - Medical School of Ankara University, Ankara, Turkey 		Add
116 Carbonic Anhydrase 9 and Caspase-9 Expression in Clear Cell Renal Cell Carcinoma: Diagnostic, Prognostic and Therapeutic Implications (891)
S Kiremitci, D Kankaya, O Tulunay, S Baltaci - Medical School of Ankara University, Ankara, Turkey 		Add